La thérapie optogénétique peut partiellement restaurer la vision chez un patient aveugle atteint de rétinopathie pigmentaire.

These contents could be interesting :

Dietary Exposure to Nitrites Associated with Increased Type 2 Diabetes Risk

Researchers from Inserm, INRAE, Université Sorbonne Paris Nord, Université Paris Cité and Cnam, as part of the Nutritional epidemiology research team (EREN-CRESS), studied the role of dietary nitrites and....

One in Four French Adults Thought to Have Some Form of Hearing Loss

A new study shows for the first time that 25% of adults in France are affected by some form of hearing loss. Disabling hearing loss, which is more severe,....

Medias

Researcher Contact

José-Alain Sahel

U968 – Institut de la Vision

rf.etisrevinu-ennobros@lehas.niala-esoj

Botond Roska

Directeur fondateur de l’IOB et professeur à l’Université de Bâle

hc.boi@aksor.dnotob

Press Contact

Sorbonne Université

rf.etisrevinu-ennobros@yzlav.noiram

rf.etisrevinu-ennobros@nihcem-ysioht_ed.erialc

Institut de la vision

gro.noisiv-tutitsni@acul-ed.aleuname

IOB

hc.boi@rethceulhcs.ardnas

Inserm

rf.mresni@esserp

Sources

Partial recovery of visual function in a blind patient after optogenetic therapy

José-Alain Sahel, Elise Boulanger-Scemama, Chloé Pagot, Angelo Arleo, Francesco Galluppi, Joseph N Martel, Simona Degli Esposti, Alexandre Delaux, Jean-Baptiste de Saint Aubert, Caroline de Montleau, Emmanuel Gutman, Isabelle Audo, Jens Duebel, Serge Picaud, Deniz Dalkara, Laure Blouin, Magali Taiel, Botond Roska

Nature Medicine, 24^th May 2021.

DOI : 10.1038/s41591-021-01351-4